2. Academic Validation
  3. Development and Preclinical Characterization of [18F]H3-2406 and [18F]H3-2407 for Positron Emission Tomography Imaging of the Histamine Subtype-3 Receptor

Development and Preclinical Characterization of [18F]H3-2406 and [18F]H3-2407 for Positron Emission Tomography Imaging of the Histamine Subtype-3 Receptor

  • J Med Chem. 2025 Aug 14;68(15):15372-15385. doi: 10.1021/acs.jmedchem.4c02924.
Zhendong Song 1,  Yinlong Li 1,  Kenneth Dahl 2 3,  Zhenkun Sun 4,  Jiahui Chen 1,  Xin Zhou 1,  Yabiao Gao 1,  Jian Rong 1,  Chunyu Zhao 1,  Katherine Yuan 1,  Ahmad F Chaudhary 1,  Jimmy S Patel 1 5,  Thomas L Collier 1,  Chongzhao Ran 6,  Kim S Muehlfenzl 7,  Achi Haider 1,  Charles S Elmore 7,  Magnus Schou 2 3,  Steven H Liang 1
Affiliations

Affiliations

  • 1 Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • 2 PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Karolinska Institutet, Stockholm 17176, Sweden.
  • 3 Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.
  • 4 Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
  • 5 Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, United States.
  • 6 Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, United States.
  • 7 Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca Pharmaceuticals, Gothenburg 43183, Sweden.
PMID: 40665705 DOI: 10.1021/acs.jmedchem.4c02924
Abstract

The histamine subtype 3 receptor (H3R) is a G protein-coupled receptor involved in various central nervous system (CNS) disorders. We herein describe the identification and preclinical evaluation of two H3R antagonists: compounds 3 (H3-2406, Ki = 2.87 nM) and 4 (H3-2407, Ki = 3.15 nM) as potential PET radioligands. Both were radiolabeled with fluorine-18 using a copper-mediated method. Among them, [18F]3 showed high radiochemical yield (32.4%), molar activity (103 GBq/μmol), and moderate brain uptake (SUV = 2.4), with regional distribution matching known H3R expression. [18F]3 also exhibited favorable pharmacokinetics, high metabolic stability and negligible efflux by transporter proteins. However, relatively high cerebellar uptake, along with dedicated blocking studies, suggested off-target binding to the sigma-1 receptor, likely due to limited selectivity over sigma-1 (69-fold). These findings highlight [18F]3 as a promising lead for H3R imaging, with future work aimed at improving its selectivity and minimizing off-target binding.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z